Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer

NCT02170090 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

789

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma
Gall Bladder Carcinoma

Interventions

DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Capecitabine

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]